Abstract
METABOTROPIC glutamate receptors (mGluRs) have been shown to contribute to nociceptive processing in the spinal cord. We have investigated the pharmacology of the mGluR agonist (1S,3R)-ACPD during inflammatory hyperalgesia in an in vitro preparation of the juvenile rat hemisected spinal cord. Superfusion of (1S,3R)-ACPD produced a concentration-dependent ventral root depolarization in naive and hyperalgesic animals with no significant difference in EC50 values (55.5 ± 6.36 μM and 51.0 ± 5.76 μM, respectively, n = 4). However, the amplitude of the maximum response was significantly enhanced by 23% in hyperalgesic compared with naive animals. The NMDA receptor antagonist D-AP5 reversed this effect, leaving the (1S,3R)- ACPD dose-response curve unchanged in naive animals. These results suggest a tonic NMDA component in the spinal cord during inflammatory hyperalgesia.
Original language | English |
---|---|
Pages (from-to) | 1201-1203 |
Number of pages | 3 |
Journal | NeuroReport |
Volume | 9 |
Issue number | 6 |
DOIs | |
State | Published - 20 Apr 1998 |
Keywords
- (1S,3R)-ACPD
- Inflammation
- Metabotropic glutamate receptors
- Spinal cord